Nirvana Life Sciences Inc
CCSE:NIRV.X0.05
CAD
0.00
(0.00%)
ISIN
CA6546522054
CUSIP
654652205
Return %
Stock
S&P 500
1Y
-37.50
14.20
3Y
-99.37
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Bruce Clark
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- 905 West Pender Street Vancouver BC Canada V6X 1L3
- IPO Date
- Mar 18, 2022
- Website
- nirvanalifescience.com
- Similar Companies
- Business
- Nirvana Life Sciences Inc. engages primarily in the development, manufacturing, and distribution of natural health products, supplements, and botanical therapeutics. The company's core product offerings include dietary supplements, natural extracts, personalized health and wellness formulations, and nutraceutical products, designed to support immune health, cognitive function, metabolic health, and overall wellness. Nirvana Life Sciences incorporates cutting-edge botanical research and quality manufacturing processes to develop proprietary formulas and plant-based health solutions. The company targets health-conscious consumers, healthcare practitioners, and retail distributors across North America, with expanding reach into international markets. Founded in 2016 and headquartered in British Columbia, Canada, Nirvana Life Sciences has built a strategic focus on natural health innovation and product efficacy. Recently, within the past 1-2 years, the company has embarked on significant business expansions including new product launches in advanced botanicals and enhanced nutraceutical formulas. Additionally, Nirvana Life Sciences has entered strategic partnerships with leading research institutions to accelerate botanical research and expand its product development capabilities. The company has also made operational enhancements to scale its manufacturing processes and widen market distribution channels, adapting to growing consumer demand for natural health products. Nirvana Life Sciences operates in the natural health and wellness industry, including business segments such as nutritional supplements, botanical extracts, and wellness product manufacturing. Its product portfolio is branded under proprietary label formulations and marketed directly and through partners to retail health stores, e-commerce platforms, and wellness professionals. The company continues to invest in innovation, compliance, and market expansion to strengthen its position in the growing global natural health sector. No recent name changes or corporate reorganizations have been reported as of the latest available data. Overall, Nirvana Life Sciences Inc. delivers an integrated suite of natural health products emphasizing botanical efficacy, manufacturing quality, and strategic growth initiatives aligned with contemporary health trends and consumer preferences. This positions the company as a dynamic player focused on advancing natural health solutions within Canada and internationally.